John Shields

1.6k total citations
33 papers, 1.4k citations indexed

About

John Shields is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, John Shields has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 7 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Genetics. Recurrent topics in John Shields's work include Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (12 papers) and Immunotherapy and Immune Responses (7 papers). John Shields is often cited by papers focused on Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (12 papers) and Immunotherapy and Immune Responses (7 papers). John Shields collaborates with scholars based in India, United Kingdom and United States. John Shields's co-authors include Robin E. Callard, Susan Smith, Jean‐Yves Bonnefoy, Walter J. Urba, Campbell Bunce, Gregory Alvord, Arden M. Morris, John T. Vetto, Andrew D. Weinberg and Rodney A. Prell and has published in prestigious journals such as Science, The Journal of Immunology and International Journal of Cancer.

In The Last Decade

John Shields

33 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Shields India 16 904 313 255 219 154 33 1.4k
Joanne T. Hom United States 17 515 0.6× 201 0.6× 265 1.0× 185 0.8× 169 1.1× 24 1.1k
Thomas Hünig Germany 25 1.7k 1.9× 306 1.0× 274 1.1× 376 1.7× 177 1.1× 53 2.1k
Patricia J. Conrad United States 18 885 1.0× 200 0.6× 430 1.7× 261 1.2× 140 0.9× 27 1.5k
S Tagawa Japan 16 901 1.0× 415 1.3× 602 2.4× 113 0.5× 64 0.4× 47 1.9k
Mary Anne Talle United States 17 1.2k 1.4× 186 0.6× 338 1.3× 569 2.6× 113 0.7× 21 1.8k
Chieko Morimoto Japan 24 950 1.1× 255 0.8× 315 1.2× 44 0.2× 133 0.9× 39 1.9k
Peter C. Wilkinson United Kingdom 8 521 0.6× 138 0.4× 236 0.9× 61 0.3× 156 1.0× 11 991
Theresa Truitt United States 10 1.0k 1.2× 356 1.1× 255 1.0× 121 0.6× 43 0.3× 10 1.4k
C Pénit France 25 1.3k 1.4× 279 0.9× 383 1.5× 189 0.9× 53 0.3× 47 1.8k
Robert H. Loblay Australia 9 1.5k 1.6× 124 0.4× 256 1.0× 377 1.7× 393 2.6× 14 2.1k

Countries citing papers authored by John Shields

Since Specialization
Citations

This map shows the geographic impact of John Shields's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Shields with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Shields more than expected).

Fields of papers citing papers by John Shields

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Shields. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Shields. The network helps show where John Shields may publish in the future.

Co-authorship network of co-authors of John Shields

This figure shows the co-authorship network connecting the top 25 collaborators of John Shields. A scholar is included among the top collaborators of John Shields based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Shields. John Shields is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cárdenas, Ana María, Erin H. Graf, Larry A. Harshyne, et al.. (2016). Human parechovirus and enterovirus initiate distinct CNS innate immune responses: Pathogenic and diagnostic implications. Journal of Clinical Virology. 86. 39–45. 11 indexed citations
2.
Kosten, Thomas R., Marc I. Rosen, Julian F. Bond, et al.. (2002). Human therapeutic cocaine vaccine: safety and immunogenicity. Vaccine. 20(7-8). 1196–1204. 151 indexed citations
3.
Weinberg, Andrew D., Rodney A. Prell, Arden M. Morris, et al.. (2000). Engagement of the OX-40 Receptor In Vivo Enhances Antitumor Immunity. The Journal of Immunology. 164(4). 2160–2169. 315 indexed citations
4.
Kim, Se‐Heon, John F. Carew, David A. Kooby, et al.. (2000). Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer. Cancer Gene Therapy. 7(9). 1279–1285. 18 indexed citations
5.
McLean, C. S., M. E. G. Boursnell, G Martín, et al.. (2000). Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.. PubMed. 60(6). 1663–70. 31 indexed citations
6.
7.
Boursnell, M. E. G., Claire Entwisle, Shiva Sivasubramaniam, et al.. (1998). Disabled Infectious Single Cycle (DISC) Herpes Simplex Virus as a Vector for Immunotherapy of Cancer. Advances in experimental medicine and biology. 451. 379–384. 10 indexed citations
8.
Shields, John, Sibylle Pochon, Jean‐Pierre Aubry, et al.. (1992). The role of CD23 and its receptor in T-cell/B-cell interaction: implications for regulation of IgE synthesis. Research in Immunology. 143(4). 425–427. 4 indexed citations
9.
Shields, John, et al.. (1992). Interleukin-4 stimulates immunoglobulin secretion by Epstein-Barr virus (EBV)-activated tonsillar B cells, and by EBV-transformed lymphoblastoid B cell lines without increasing cell division. International Journal of Clinical & Laboratory Research. 22(1-4). 95–99. 7 indexed citations
10.
11.
12.
Jansen, Kathrin U., John Shields, John Gordon, et al.. (1991). Expression of Human Recombinant CD23 in Insect Cells. Journal of Receptor Research. 11(1-4). 507–520. 12 indexed citations
13.
Shields, John, et al.. (1991). Human recombinant CD23 (full-length and soluble forms) expressed in insect cells bind IgE.. PubMed. 29. 50–62. 3 indexed citations
14.
Bonnefoy, Jean‐Yves, John Shields, & Jean‐Jacques Mermod. (1990). Inhibition of human interleukin 4‐induced IgE synthesis by a subset of anti‐CD23/FcϵRII monoclonal antibodies. European Journal of Immunology. 20(1). 139–144. 66 indexed citations
15.
16.
Smith, Susan, John Shields, & Robin E. Callard. (1989). Human t cell-replacing factor(s): a comparison of recombinant and purified human b cell growth and differentiation factors. European Journal of Immunology. 19(11). 2045–2049. 7 indexed citations
17.
Shields, John, et al.. (1988). Modulation of intestinal hypersensitivity reactions in the rat by the anti allergic drugs beclomethasone dipropionate and disodium cromoglycate. Medical science research. 16(15). 811–812. 3 indexed citations
18.
Shields, John, Susan Smith, Stephan Ströbel, et al.. (1988). Response of LFA-l-deficient B cells to interleukin 4 (BSF-1) and low molecular weight B cell growth factor (BCGFlow). European Journal of Immunology. 18(2). 255–259. 6 indexed citations
19.
Shields, John, Susan Smith, Roland J. Levinsky, et al.. (1987). The response of selected human B cell lines to B cell growth and differentiation factors. European Journal of Immunology. 17(4). 535–540. 15 indexed citations
20.
Callard, Robin E., Susan Smith, John Shields, & Roland J. Levinsky. (1986). T cell help in human antigen‐specific antibody responses can be replaced by interleukin 2. European Journal of Immunology. 16(9). 1037–1042. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joanne T. Hom Breakdown of academic impact, for papers by Thomas Hünig Breakdown of academic impact, for papers by Patricia J. Conrad Breakdown of academic impact, for papers by S Tagawa Breakdown of academic impact, for papers by Mary Anne Talle Breakdown of academic impact, for papers by Chieko Morimoto Breakdown of academic impact, for papers by Peter C. Wilkinson Breakdown of academic impact, for papers by Theresa Truitt Breakdown of academic impact, for papers by C Pénit Breakdown of academic impact, for papers by Robert H. Loblay
Rankless by CCL
2026